Common Contracts
2 similar Purchase Agreement contracts by Genentech Inc, Pride International Inc
GENENTECH, INC. $500,000,000, 4.40% Senior Notes due 2010 $1,000,000,000, 4.75% Senior Notes due 2015 $500,000,000, 5.25% Senior Notes due 2035 Purchase AgreementPurchase Agreement • November 4th, 2005 • Genentech Inc • Pharmaceutical preparations • New York
Genentech, Inc., a corporation organized under the laws of Delaware (the "Company"), proposes to issue and sell to the several parties named in Schedule I hereto (the "Initial Purchasers"), for whom you (the "Representatives") are acting as representatives, $500,000,000 aggregate principal amount of its 4.40% Senior Notes due 2010 (the "2010 Notes"), $1,000,000,000 aggregate principal amount of its 4.75% Senior Notes due 2015 (the "2015 Notes") and $500,000,000 aggregate principal amount of its 5.25% Senior Notes due 2035 (the "2035 Notes," and together with the 2010 Notes and the 2035 Notes, the "Securities"). The Securities are to be issued under an indenture, to be dated as of the Closing Date, between the Company and The Bank of New York Trust Company, N.A., as trustee (the "Trustee"), as supplemented by an Officers' Certificate to be dated as of the Closing Date (as supplemented, the "Indenture"). Holders of the Securities will have the benefit of a registration rights agreement (
PRIDE INTERNATIONAL, INC. 7 3/8% Senior Notes due 2014 Purchase AgreementPurchase Agreement • June 29th, 2004 • Pride International Inc • Oil & gas field services, nec • New York
The opinion of the counsel for the Company, to be delivered pursuant to Section 6(d) of the Purchase Agreement, shall be to the effect that:
